Domov › Adenokarcinóm pažeráka › Minnesota

Klinické štúdie Adenokarcinóm pažeráka v štáte Minnesota

14 štúdií pre Adenokarcinóm pažeráka hľadá účastníkov v zariadeniach v štáte Minnesota.

Mestá v štáte Minnesota

Oficiálny text štúdie (anglicky)

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

Sanford Joe Lueken Cancer Center, Bemidji
Essentia Health Saint Joseph's Medical Center, Brainerd
Mercy Hospital, Coon Rapids
a 12 ďalších

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06203600

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

Riverwood Healthcare Center, Aitkin
Essentia Health - Baxter Clinic, Baxter
Sanford Joe Lueken Cancer Center, Bemidji
a 46 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05677490

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

Mayo Clinic in Rochester, Minnesota, Rochester

Prebieha náborFáza 2/3

Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07221149

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Mayo Clinic Rochester, Rochester

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT07277413

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Research Site, Rochester

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06005493

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

Mayo Clinic, Rochester

Prebieha nábor

Vek 18 až 89 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT05753748

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Burnsville
Research Site, Duluth
Research Site, Minneapolis
a 1 ďalších

Prebieha náborFáza 3

Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07431281

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Normunity Investigational Site, Minneapolis

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 8. 2026 · NCT07182149

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

M Health Fairview University of Minnesota Medical Center, Minneapolis

Prebieha náborFáza 1/2

Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 8. 2026 · NCT06330064

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Allina Health Cancer Institute - Mercy Hospital, Coon Rapids
Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
Allina Health Cancer Institute - United Hospital, Saint Paul
a 1 ďalších

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 6. 7. 2026 · NCT04389632

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

Mayo Clinic, Rochester

Prebieha nábor

Vek 18 až 89 · Všetky pohlavia · Aktualizované 1. 7. 2026 · NCT05530343

Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples

Mayo Clinic in Rochester, Rochester

Prebieha nábor

Vek 18 až 90 · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT06071845

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

Mayo Clinic Rochester, Rochester

Prebieha náborFáza 1

Vek 18 a viac · Všetky pohlavia · Aktualizované 8. 5. 2026 · NCT05954312

Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma

Mayo Clinic Health Systems - Austin, Austin
Mayo Clinic Rochester, Rochester

Prebieha náborVítaní zdravých dobrovoľníkov

Vek 18 až 90 · Všetky pohlavia · Aktualizované 26. 1. 2026 · NCT03961945

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.